CAMBRIDGE, Mass., Jan. 27, 2026 /PRNewswire/ -- Insilico Medicine, a clinical-stage biotechnology company powered by generative AI, and Qilu Pharmaceutical Group, a major comprehensive modern ...
In today’s Pharmaceutical Executive Daily, the FDA issues a Complete Response Letter for Disc Medicine’s bitopertin in EPP, ...
Insilico Medicine, a clinical-stage biotechnology company powered by generative AI, and Qilu Pharmaceutical Group, a major comprehensive modern pharmaceutical enterprise in China, as well as its ...
RICHMOND, Va. -- The Alliance for Building Better Medicine, which is comprised of more than 20 companies, colleges, and nonprofits in Richmond and Petersburg, has been designated as a technology and ...
AI in pharmaceuticals is set to transform drug discovery, clinical trials, manufacturing, and marketing by analysing vast datasets to speed up processes, reduce costs, and enable personalised medicine ...
In today’s ever-changing market place, pharmaceutical companies are challenged to reach, engage and persuade physicians in new, more effective ways. With changing behavioral influences, rising ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results